Biotech / PharmaPittsburgh

CytoAgents

Biotech / Pharma

CytoAgents is a clinical-stage biotechnology company developing innovative pharmaceutical products for life-threatening conditions. Its lead asset, CTO1681, is an oral small molecule immune modulator designed to prevent and treat Cytokine Release Syndrome and other inflammatory conditions through selective prostacyclin/prostaglandin receptor signaling.

Founded

Region

Pittsburgh

Investors

Innovation Works

People

About Pittsburgh

Pittsburgh's tech economy grew out of Carnegie Mellon's robotics program, one of the oldest and deepest in the country, with the University of Pittsburgh's own research base sitting right alongside it — two major universities anchoring one relatively compact city. It's also a place that didn't start as a tech hub at all: this was steel country for a century, and that engineering-and-manufacturing inheritance still shows up in what the region builds — robotics, autonomy, and deep tech that comes out of hard industrial know-how, not a recent software boom.

Region Stats

Total firms 299

VC / investors 6

Companies 286

Universities 7

Known For

Robotics

Autonomy

Deep Tech